home / stock / hook / hook articles

HOOK Articles, HOOKIPA Pharma Inc.

Stock Information
Company Name: HOOKIPA Pharma Inc.
Stock Symbol: HOOK
Market: NYSE
Website: hookipapharma.com
Menu
HOOK HOOK Quote HOOK Short HOOK News HOOK Articles HOOK Message Board
Get HOOK Alerts

News, Short Squeeze, Breakout and More Instantly...
HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting | Benzinga

Company will present promising preliminary progression-free survival and overall survival data for patients with combined positive score (CPS) ??...
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday? | Benzinga

Wednesday, HOOKIPA Pharma Inc (NASDAQ:HOOK) received clearance from the FDA for its Investigational New Drug (IND) application for H...

Roche's Lymphoma Drug With Chemo Extends Survival In Pretreated Patients | Benzinga

Monday, Roche Holdings AG (OTC:RHHBY) announced topline data from Phase 3 STARGLO study of Columvi (glofitamab) in combination ...

HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference | Benzinga

NEW YORK and VIENNA, Austria, March 06, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ:HOOK, ‘HOOKIPA')), a company developing a ne...
Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month | Benzinga

Tuesday, Repare Therapeutics Inc (NASDAQ:RPTX) announced to regain global development and commercialization rights to camonsertib (RP-350...

Roche Walks Away From HOOKIPA Pharma-Partnered KRAS-Focused Cancer Deal | Benzinga

HOOKIPA Pharma Inc (NASDAQ:HOOK) will focus its resources on prioritizing the clinical development of a randomized trial for its HB-200 progra...

AbbVie, Arch Capital, Gilead Sciences And A Telecom Giant On CNBC's 'Final Trades' | Benzinga

On CNBC’s "Halftime Report Final Trades," Rob Sechan of NewEdge Wealth said Gilead Sciences, Inc. (NASDAQ: GILD) is an inexpensive...
HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization | Benzinga

NEW YORK and VIENNA, Austria, Jan. 16, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ:HOOK, ‘HOOKIPA')), a company developing a new...

Nasdaq Gains 100 Points; CarMax Earnings Top Views | Benzinga

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.37% to ...

Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings. KMX reported a t...
Next 10